1. Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett J, et al. Acute myeloid leukaemia. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. eds,. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer Press;2001. p. 75–108.
2. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood. 2000; 96:1297–308.
3. Chen SJ, Wang ZY, Chen Z. Acute promyelocytic leukemia: from clinic to molecular biology. Stem Cells. 1995; 13:22–31.
Article
4. Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol. 1997; 24:92–102.
5. Viguie F. t(11;17)(q13;q21). Atlas Genet Cytogenet Oncol Haematol. May 1998. http://www.infobiogen.fr/services/chromcancer/Anomalies/t1117ID1126.html.
Article
6. Sorensen PH, Chen CS, Smith FO, Arthur DC, Domer PH, Bernstein ID, et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest. 1994; 93:429–37.
Article
7. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia. 1996; 10:74–82.
8. Huret JL. 11q23 rearrangements in leukemia. Atlas Genet Cytogenet Oncol Haematol August. 2003. http://www.infobiogen.fr/services/chromcancer/Anomalies/11q23ID1030.html.
9. Meyer C, Schneider B, Jakob S, Strehl S, Attarbaschi A, Schnittger S, et al. The MLL recombinome of acute leukemias. Leukemia. 2006; 20:777–84.
Article
10. Shekhter-Levin S, Gollin SM, Kaplan SS, Redner RL. Involvement of the MLL and RARα genes in a patient with acute monocytic leukemia with t(11;17)(q23;q12). Leukemia. 2000; 14:520–2.
11. Dube S, Fetni R, Hazourli S, Champagne M, Lemieux N. Rearrangement of the MLL gene and a region proximal to the RARα gene in a case of acute myelocytic leukemia M5 with a t(11;17)(q23;q21). Cancer Genet Cytogenet. 2003; 145:54–9.
12. Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, et al. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc Natl Acad Sci USA. 1994; 91:8107–11.
Article
13. Strehl S, Borkhardt A, Slany R, Fuchs UE, Konig M, Haas OA. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene. 2003; 22:157–60.
Article
14. Moore SD, Strehl S, Dal Cin P. Acute myelocytic leukemia with t(11;17)(q23;q12-q21) involves a fusion of MLL and AF17. Cancer Genet Cytogenet. 2005; 157:87–9.
Article
15. Kang LC, Smith SV, Kaiser-Rogers K, Rao K, Dunphy CH. Two cases of acute myeloid leukemia with t(11;17) associated with varying morphology and immunophenotype: rearrangement of the MLL gene and a region proximal to the RARalpha gene. Cancer Genet Cytogenet. 2005; 159:168–73.
16. Reeves BR, Kempski H, Jani K, Borrow J, Howe K, Solomon E, et al. A case of acute monocytic leukemia with t(11;17) involving a rearrangement of MLL-1 and a region proximal to the RARA gene. Cancer Genet Cytogenet. 1994; 74:50–3.
Article
17. Classen CF, Teigler-Schlegel A, Rottgers S, Reinhardt D, Dohner K, Debatin KM. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid. Ann Hematol. 2005; 84:774–80.
Article